DERMASEQ
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

DERMASEQ Trademark

Serial Number: 86843003

DERMASEQ is a trademark filed by Adaptive Biotechnologies Corporation on December 8, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Adaptive Biotechnologies Corporation (31 trademarks)

1551 Eastlake Avenue East Suite 200
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

December 8, 2015

Registration Date

Not Registered

Goods & Services

Medical services; medical analysis and diagnostic services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; providing medical diagnostic testing for the detection, diagnosis, and treatment of cutaneous T-cell lymphoma and skin-related cancers; providing medical testing for immune responses to immunotherapy or cancer treatment

Medical and scientific research in the fields of cutaneous T-cell lymphoma and skin-related cancers and diagnosing and treating same; scientific research, development, engineering, testing, and analytical services for diagnosing and treating cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for diagnosing cutaneous T-cell lymphoma and skin-related cancers; providing analysis, evaluation, and clinical reports of a patient's condition with regard to cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly; research and development of diagnostic test kits for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; laboratory research and testing services relating to detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reporting of those test results to healthcare professionals to determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2018 TCCA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 27, 2016 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 27, 2016 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2016 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2016 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 12, 2015 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2015 NWOS
NEW APPLICATION ENTERED
Dec 11, 2015 NWAP